In Regard to Shortall et al

Affiliations

¹ Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia; Department of Physics, University of Western Australia, Crawley, Australia; 5D Clinics, Claremont, Australia.
² Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia.
³ School of Physics, University of Sydney, Camperdown, Australia.
⁴ School of Physics, University of Sydney, Camperdown, Australia; Department of Medical Physics, Liverpool Cancer Centre, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
⁵ School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, Australia; Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, Australia.
⁶ School of Physics, University of Sydney, Camperdown, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia; School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, Australia; CSIRO, Herston, Australia.
⁷ GenesisCare, Alexandria, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
⁸ South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia.
⁹ 5D Clinics, Claremont, Australia; GenesisCare WA, Wembley, Australia; School of Surgery, University of Western Australia, Crawley, Australia.
¹⁰ Radiotherapy Department, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
¹¹ MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom.
¹² Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, United Kingdom.
¹³ Academic UroOncology Unit, The Institute of Cancer Research and the Royal Marsden NHS Trust, London, United Kingdom.

PMID: 35101196
DOI: 10.1016/j.ijrobp.2021.10.140

Comment

In Regard to Shortall et al

Martin A Ebert et al. Int J Radiat Oncol Biol Phys. 2022.

. 2022 Mar 1;112(3):831-833.

doi: 10.1016/j.ijrobp.2021.10.140.

Authors

Affiliations

¹ Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia; Department of Physics, University of Western Australia, Crawley, Australia; 5D Clinics, Claremont, Australia.
² Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia.
³ School of Physics, University of Sydney, Camperdown, Australia.
⁴ School of Physics, University of Sydney, Camperdown, Australia; Department of Medical Physics, Liverpool Cancer Centre, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
⁵ School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, Australia; Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, Australia.
⁶ School of Physics, University of Sydney, Camperdown, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia; School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, Australia; CSIRO, Herston, Australia.
⁷ GenesisCare, Alexandria, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
⁸ South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia.
⁹ 5D Clinics, Claremont, Australia; GenesisCare WA, Wembley, Australia; School of Surgery, University of Western Australia, Crawley, Australia.
¹⁰ Radiotherapy Department, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
¹¹ MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom.
¹² Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, United Kingdom.
¹³ Academic UroOncology Unit, The Institute of Cancer Research and the Royal Marsden NHS Trust, London, United Kingdom.

PMID: 35101196
DOI: 10.1016/j.ijrobp.2021.10.140

No abstract available

PubMed Disclaimer

Comment in

In Reply to Ebert et al.
Shortall J, Palma G, Mistry H, Osorio EV, McWilliam A, Choudhury A, Aznar M, van Herk M, Green A. Shortall J, et al. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):833-834. doi: 10.1016/j.ijrobp.2021.10.154. Int J Radiat Oncol Biol Phys. 2022. PMID: 35101197 No abstract available.

Comment on

Flogging a Dead Salmon? Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials.
Shortall J, Palma G, Mistry H, Vasquez Osorio E, McWilliam A, Choudhury A, Aznar M, van Herk M, Green A. Shortall J, et al. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):696-699. doi: 10.1016/j.ijrobp.2021.01.017. Epub 2021 Apr 20. Int J Radiat Oncol Biol Phys. 2021. PMID: 34089676 No abstract available.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

In Regard to Shortall et al

Affiliations

In Regard to Shortall et al

Authors

Affiliations

Comment in

Comment on

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources